39 results on '"Morishita, E."'
Search Results
2. PB0985 Cure of Congenital Purpura Fulminant by Neonatal Genome Editing to Express an Engineered Protein C in Mice
3. PF756 DONOR UNC-93 HOMOLOG B1 GENETIC VARIATION PREDICTS SURVIVAL OUTCOMES AFTER UNRELATED BONE MARROW TRANSPLANTATION
4. Unsteady Aerodynamic Characteristics of Deformable Airfoil
5. Plasma Levels of Thrombomodulin and Active Plasminogen Activator Inhibitor Increase in Disseminated Intravascular Coagulation with Multiple Organ Failure
6. Inverse Schwartz–Christoffel panel method
7. BIPLANE AERODYNAMICS REVISITED
8. A case of acquired FXIII deficiency with severe bleeding symptoms
9. Crystal structures of adenomatous polyposis coli and its complex with Sam68
10. Haemostatic management of surgery for imperforate anus in a patient with 13q deletion syndrome with combined deficiency of factors VII and X
11. Selective inducible nitric oxide synthase inhibition attenuates organ dysfunction and elevated endothelin levels in LPS‐induced DIC model rats
12. Beneficial effect of JTV-803, a new synthetic inhibitor of activated factor X, against both lipopolysaccharide-induced and tissue factor-induced disseminated intravascular coagulation in rat models
13. Spreadsheet fluid dynamics for turbulence in a two-dimensional channel flow
14. Vitamin K Administration to Elderly Patients with Osteoporosis Induces No Hemostatic Activation, Even in Those with Suspected Vitamin K Deficiency
15. All-trans retinoic acid is partially effective against lipopolysaccharide-induced but not against tissue-factor-induced disseminated intravascular coagulation in rat models
16. Depressed plasma activity of plasminogen or α2 plasmin inhibitor is not due to consumption coagulopathy in septic patients with disseminated intravascular coagulation
17. Experimental and computational investigation of supersonic cavity flows
18. Elevated plasma levels of free-form of TFPI antigen in hypercholesterolemic patients
19. Elevated levels of free tissue factor pathway inhibitor antigen in cases of disseminated intravascular coagulation caused by various underlying diseases
20. Prednisolone inhibits endotoxin-induced disseminated intravascular coagulation and improves mortality in rats
21. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death
22. Hypercoagulability and high lipoprotein(a) levels in patients with aplastic anemia receiving cyclosporine
23. Anti-erythropoietin receptor monoclonal antibody: epitope mapping, quantification of the soluble receptor, and detection of the solubilized transmembrane receptor and the receptor-expressing cells
24. Role of tissue factor in disseminated intravascular coagulation
25. Levels of activated factor VII in patients with disseminated intravascular coagulation [letter]
26. Relationship between elevation in the plasma concentration of elastase-??1 proteinase inhibitor complex (E-??1PI) and haemostatic parameters during haemodialysis
27. Recombinant hirudin for the treatment of disseminated intravascular coagulation in patients with haematological malignancy
28. Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers
29. Two genetic defects in a patient with complete deficiency of the b- subunit for coagulation factor XIII
30. Successful treatment of a patient with idiopathic factor VIII inhibitor with double filtration plasmapheresis and steroid administration
31. Prothrombin Himi: a compound heterozygote for two dysfunctional prothrombin molecules (Met-337-->Thr and Arg-388-->His)
32. Prothrombin Himi: a compound heterozygote for two dysfunctional prothrombin molecules (Met-337-->Thr and Arg-388-->His)
33. Role of endothelin in disseminated intravascular coagulation
34. Prothrombin fragment F1 + 2 and thrombin—antithrombin III complex are useful markers of the hypercoagulable state in atrial fibrillation
35. Prothrombin fragment F1 + 2 and thrombin—antithrombin III complex are useful markers of the hypercoagulable state in atrial fibrillation
36. The course of disseminated intravascular coagulation is predicted by changes in thrombin???antithrombin III complex levels???is there any difference between treatment with standard heparin or low-molecular-weight heparin?
37. Role of plasminogen activator inhibitor-1 (PAI-1) in DIC
38. Equilibrium and kinetic properties of LaNi5 and MmNi4.5Al0.5 deuterides
39. Heat transmission analysis of metal hydride beds
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.